Equities

ProQR Therapeutics NV

ProQR Therapeutics NV

Actions
  • Price (EUR)1.55
  • Today's Change-0.021 / -1.33%
  • Shares traded--
  • 1 Year change+9.28%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(28)(65)(62)
Depreciation/depletion2.512.522.33
Non-Cash items(4.07)3.0411
Cash taxes paid, supplemental(0.08)0.100.12
Cash interest paid, supplemental0.793.762.25
Changes in working capital51(9.18)23
Total cash from operations22(69)(26)
INVESTING
Capital expenditures(1.37)(0.71)(0.48)
Other investing and cash flow items, total5.650.010.06
Total cash from investing4.28(0.7)(0.43)
FINANCING
Financing cash flow items------
Total cash dividends paid------
Issuance (retirement) of stock, net0.3514110
Issuance (retirement) of debt, net(2.63)(45)27
Total cash from financing(2.28)(31)137
NET CHANGE IN CASH
Foreign exchange effects0.607.351.29
Net change in cash24(93)112
Net cash-begin balance/reserved for future use9518876
Net cash-end balance/reserved for future use11995188
SUPPLEMENTAL INCOME
Depreciation, supplemental2.512.522.33
Cash interest paid, supplemental0.793.762.25
Cash taxes paid, supplemental(0.08)0.100.12
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.